ENLITE PD:对帕金森病的睡眠障碍进行随机临床试验
Aleksandar Videnovic1,2, Christopher S Coffey3, Elizabeth B Klerman1
1Department of Neurology, Mass General Brigham, Boston, Massachusetts, USA.
Movement disorders : official journal of the Movement Disorder Society
|September 6, 2025
概括
这项研究发现,每天一次或两次的明亮白光疗法都没有显著改善帕金森病患者的睡眠. 照明疗法是安全的,耐受性很好,在所有组中都观察到良好的坚持.
科学领域:
- 神经学
- 睡眠医学
- 时间生物学
背景情况:
- 已知照明疗法可以改善帕金森病 (PD) 的睡眠障碍.
- 在PD中,对LT的最佳参数,特别是频率,需要进一步调查.
- 这项研究解决了对PD相关睡眠问题的有效LT方案的需求.
研究的目的:
- 要确定每天一次或两次的明亮白光疗法 (BWLT) 是否能改善帕金森病患者的睡眠.
- 将每周一次的BWLT和每天两次的暗红光疗法 (DRLT) 作为对照干预措施进行比较.
- 评估不同LT频率对疲劳和参与者的坚持的影响.
主要方法:
- 一个为期16周的随机第二阶段的假控制试验.
- 参与者 (n=150) 接受了为期8周的每天两次BWLT,每天一次BWLT,每周一次BWLT或每天两次DRLT.
- 主要结局:帕金森病睡眠量表-2 (PDSS-2) 评分的变化;次要结局:帕金森病疲劳量表 (PFS-16) 和坚持.
主要成果:
- 没有PDSS-2得分的显著改善符合每日BWLT的第三阶段试验的标准.
- 所有测试的光疗方案都显示出安全性和良好的坚持性 (63% - 86%).
- 与每天两次的DRLT相比,每周一次的BWLT作为一个非劣势的对照.
结论:
- 在ENLITE- PD试验中,没有达到将每日LT推向第3阶段的首要终点.
- 对于帕金森病患者来说,光疗是一种安全且耐受良好的干预措施.
- 需要进一步的研究来优化照明治疗的参数,以控制PD的睡眠障碍.
更多相关视频
09:03Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
Published on: March 28, 2025
607
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
590
相关概念视频
Parkinson's Disease: Treatment
375
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
375
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
Management of Insomnia
319
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
319
REM Sleep Behavior Disorder
378
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
378
